乏氧组织显像剂研究最新进展
-
摘要: 乏氧组织显像剂能选择性地滞留在乏氧组织或细胞中,并通过核医学显像探测组织缺氧及其程度。乏氧显像能直接提供任何器官中组织存活但有功能障碍的依据,这些信息在临床诊断决策中起到重要作用,尤其是在心、脑血管疾病和实体瘤的诊断方面。本文简要介绍乏氧组织显像剂与乏氧显像的特点及其研究的最新进展。
-
[1] Stone HB et al. Radiat Res, 1993; 136:422~434 [2] Nunn A et al. Eur J Nucl Med, 1995; 22(3):265~80 [3] Edwards DI. J Antimicrob Chemother, 1993;31:9~20 [4] Yeh SH et al. Eur J Nucl Med, 1996; 23(10):1378~1383 [5] DissmaInn PD et al. Chir Forum Exp Klin Forsch, 1997:221~227 [6] Lim JL et al. J Nucl Med, 1994; 35:6 P [7] Shine CY et al. J Labelled Compd Radio Pharm, 1997; 39:70 [8] Jelong JM et al. J Labelled Compd Radio-pharm, 1997; 39:349 [9] Schneider RF et al. Quarterly J Nucl Med,1995; 39(1):41 [10] Schneider RF et al. J Labelled Compd Radio-pharm, 1997; 39(7):541~547 [11] Cowan DSM et al. Br J Cancer, 1996; 74(Sup-pl):S264~S266 [12] Okada RD et al. Eur J Nucl Med, 1996; 23(4):443~447 [13] Linder ICE et al. J Labened Compd Radio-pharm, 1995; 37:202 [14] Kuczynski B et al. J Nucl Cardio, 1995; 4:S 28(abs) [15] Howard W et al. J Nucl Med, 1998; 39(4):598~607 [16] Zhang Z et al. J Labelled Compd Radiophann,1995; 37:205 [17] Zhang Z et al. J Nucl Med, 1994; 35:472 [18] Archer CM et al. Technetium labelled agents for imaging tissue hypoxia in vivo. In:Nicoli-ni Met al, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Padova, I-taly:SGE Ditoriali Publishers:1995; 535~539 [19] Okada RD et al. Circulation, 1997; 95(7):1892~1899 [20] Okada RD et al. Circulation, 1998; 97(25):2557~2566 [21] Fukuchi K et al. Eur J Nucl Med, 1998; 25(4):361~366 [22] Cook GJR et al. J Nucl Med, 1998; 39(1):99~103 [23] Taniuchi H et al. J Nucl Med, 1997; 38(7):1130~1134 [24] Shelton M E et al. J Nucl Med, 1989; 30(11):1843~1847 [25] Blower PJ et al. Nucl Med Biol, 1996; 23:957~980 [26] Fujibayashi Y et al. J Nucl Med, 1997; 38(7):1155~1160 [27] Jason L JD et al. Eur J Nucl Med, 1998; 25(7):788~792
点击查看大图
计量
- 文章访问数: 1137
- HTML全文浏览量: 203
- PDF下载量: 2